AKT, which is activated by PI3K or phosphatidylinositol-dependent kinase (PDK), exhibits dysregulated expression or activation in various cancers, including ovarian, lung, and pancreatic cancers, in the context of growth factors, inflammation, and DNA damage. The gene discussed is PIK3CD; the disease is cancer.